The Gym of the Future Is Here.
See what’s changing and where operators are investing.
NewLimit has reaised $435M, led by Peter Thiel's Founders Fund, to bring an age-reversing medicine to human trial next year.
NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised $45 million from Eli Lilly, Duke, and more to advance its anti-aging medicines.
NewLimit, a biotech company, is on a mission to reverse the features of aging by manipulating cell age without changing cell type.
Sign Up to Our Newsletter
